China · Delayed Price · Currency is CNY Betta Pharmaceuticals Statistics
Total Valuation
SHE:300558 has a market cap or net worth of CNY 21.27 billion. The enterprise value is 23.29 billion.
| Market Cap | 21.27B |
| Enterprise Value | 23.29B |
Important Dates
The last earnings date was Friday, August 21, 2026.
| Earnings Date | Aug 21, 2026 |
| Ex-Dividend Date | Jun 9, 2026 |
Share Statistics
SHE:300558 has 420.73 million shares outstanding. The number of shares has decreased by -1.15% in one year.
| Current Share Class | 420.73M |
| Shares Outstanding | 420.73M |
| Shares Change (YoY) | -1.15% |
| Shares Change (QoQ) | +2.02% |
| Owned by Insiders (%) | 2.34% |
| Owned by Institutions (%) | 18.17% |
| Float | 238.28M |
Valuation Ratios
The trailing PE ratio is 45.31 and the forward PE ratio is 32.20.
| PE Ratio | 45.31 |
| Forward PE | 32.20 |
| PS Ratio | 5.52 |
| PB Ratio | 3.20 |
| P/TBV Ratio | 5.89 |
| P/FCF Ratio | 79.56 |
| P/OCF Ratio | 24.21 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.91, with an EV/FCF ratio of 87.14.
| EV / Earnings | 49.82 |
| EV / Sales | 6.04 |
| EV / EBITDA | 19.91 |
| EV / EBIT | 38.19 |
| EV / FCF | 87.14 |
Financial Position
The company has a current ratio of 0.85, with a Debt / Equity ratio of 0.37.
| Current Ratio | 0.85 |
| Quick Ratio | 0.53 |
| Debt / Equity | 0.37 |
| Debt / EBITDA | 2.11 |
| Debt / FCF | 9.24 |
| Interest Coverage | 8.27 |
Financial Efficiency
Return on equity (ROE) is 7.28% and return on invested capital (ROIC) is 5.23%.
| Return on Equity (ROE) | 7.28% |
| Return on Assets (ROA) | 3.91% |
| Return on Invested Capital (ROIC) | 5.23% |
| Return on Capital Employed (ROCE) | 7.40% |
| Weighted Average Cost of Capital (WACC) | 6.28% |
| Revenue Per Employee | 2.16M |
| Profits Per Employee | 261,942 |
| Employee Count | 1,785 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 2.52 |
Taxes
In the past 12 months, SHE:300558 has paid 146.67 million in taxes.
| Income Tax | 146.67M |
| Effective Tax Rate | 24.66% |
Stock Price Statistics
The stock price has decreased by -25.02% in the last 52 weeks. The beta is 0.45, so SHE:300558's price volatility has been lower than the market average.
| Beta (5Y) | 0.45 |
| 52-Week Price Change | -25.02% |
| 50-Day Moving Average | 61.03 |
| 200-Day Moving Average | 51.24 |
| Relative Strength Index (RSI) | 39.96 |
| Average Volume (20 Days) | 20,315,477 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300558 had revenue of CNY 3.85 billion and earned 467.57 million in profits. Earnings per share was 1.12.
| Revenue | 3.85B |
| Gross Profit | 2.98B |
| Operating Income | 609.95M |
| Pretax Income | 594.86M |
| Net Income | 467.57M |
| EBITDA | 1.17B |
| EBIT | 609.95M |
| Earnings Per Share (EPS) | 1.12 |
Balance Sheet
The company has 455.75 million in cash and 2.47 billion in debt, with a net cash position of -2.02 billion or -4.79 per share.
| Cash & Cash Equivalents | 455.75M |
| Total Debt | 2.47B |
| Net Cash | -2.02B |
| Net Cash Per Share | -4.79 |
| Equity (Book Value) | 6.64B |
| Book Value Per Share | 15.75 |
| Working Capital | -313.66M |
Cash Flow
In the last 12 months, operating cash flow was 878.62 million and capital expenditures -611.30 million, giving a free cash flow of 267.32 million.
| Operating Cash Flow | 878.62M |
| Capital Expenditures | -611.30M |
| Depreciation & Amortization | 556.88M |
| Net Borrowing | 30.55M |
| Free Cash Flow | 267.32M |
| FCF Per Share | 0.64 |
Margins
Gross margin is 77.21%, with operating and profit margins of 15.83% and 12.13%.
| Gross Margin | 77.21% |
| Operating Margin | 15.83% |
| Pretax Margin | 15.44% |
| Profit Margin | 12.13% |
| EBITDA Margin | 30.28% |
| EBIT Margin | 15.83% |
| FCF Margin | 6.94% |
Dividends & Yields
This stock pays an annual dividend of 0.15, which amounts to a dividend yield of 0.29%.
| Dividend Per Share | 0.15 |
| Dividend Yield | 0.29% |
| Dividend Growth (YoY) | -24.60% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 27.33% |
| Buyback Yield | 1.15% |
| Shareholder Yield | 1.45% |
| Earnings Yield | 2.20% |
| FCF Yield | 1.26% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SHE:300558 has an Altman Z-Score of 4.71 and a Piotroski F-Score of 7.
| Altman Z-Score | 4.71 |
| Piotroski F-Score | 7 |